{"id":"https://openalex.org/W2157310187","doi":"https://doi.org/10.1111/j.1365-2265.2005.02403.x","title":"Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results","display_name":"Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results","alternate_titles":[],"publication_year":2005,"publication_date":"2005-12-01","ids":{"openalex":"https://openalex.org/W2157310187","doi":"https://doi.org/10.1111/j.1365-2265.2005.02403.x","mag":"2157310187","pmid":"https://pubmed.ncbi.nlm.nih.gov/16402938"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2265.2005.02403.x","doi":"https://doi.org/10.1111/j.1365-2265.2005.02403.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2265.2005.02403.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2157310187"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012196997","display_name":"Antongiulio Faggiano","orcid":"https://orcid.org/0000-0002-9324-3946","observed_orcids":["https://orcid.org/0000-0002-9324-3946"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antongiulio Faggiano","raw_affiliation_strings":["Department of Nuclear Medicine and Endocrinological Oncology, Gustave-Roussy Institute, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine and Endocrinological Oncology, Gustave-Roussy Institute, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081409867","display_name":"Sophie Leboulleux","orcid":"https://orcid.org/0000-0002-0771-3033","observed_orcids":["https://orcid.org/0000-0002-0771-3033","https://orcid.org/0000-0002-4824-8502"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sophie Leboulleux","raw_affiliation_strings":["Department of Nuclear Medicine and Endocrinological Oncology, Gustave-Roussy Institute, Villejuif,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine and Endocrinological Oncology, Gustave-Roussy Institute, Villejuif,","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084162832","display_name":"Jacques Young","orcid":"https://orcid.org/0000-0001-9286-5631","observed_orcids":["https://orcid.org/0000-0001-9286-5631"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210162942","display_name":"Bic\u00eatre Hospital","ror":"https://ror.org/05c9p1x46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210162942","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacques Young","raw_affiliation_strings":["Endocrinology Unit, Centre Hospitalier Universitaire de Bice\u0302tre, Assistance Publique-Ho\u0302pitaux de Paris, and Faculte\u0301 de Me\u0301decine Paris-Sud, Paris, France","Endocrinology Unit, Centre Hospitalier Universitaire de Bic\u00eatre, Assistance Publique-H\u00f4pitaux de Paris, and Facult\u00e9 de M\u00e9decine Paris-Sud, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology Unit, Centre Hospitalier Universitaire de Bice\u0302tre, Assistance Publique-Ho\u0302pitaux de Paris, and Faculte\u0301 de Me\u0301decine Paris-Sud, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210162942"]},{"raw_affiliation_string":"Endocrinology Unit, Centre Hospitalier Universitaire de Bic\u00eatre, Assistance Publique-H\u00f4pitaux de Paris, and Facult\u00e9 de M\u00e9decine Paris-Sud, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210162942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041250553","display_name":"Martin Jean Schlumberger","orcid":"https://orcid.org/0000-0003-2599-4817","observed_orcids":["https://orcid.org/0000-0003-2599-4817"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Schlumberger","raw_affiliation_strings":["Department of Nuclear Medicine and Endocrinological Oncology, Gustave-Roussy Institute, Villejuif,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine and Endocrinological Oncology, Gustave-Roussy Institute, Villejuif,","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067116958","display_name":"\u00c9ric Baudin","orcid":"https://orcid.org/0000-0002-2198-3582","observed_orcids":["https://orcid.org/0000-0002-2198-3582"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Eric Baudin","raw_affiliation_strings":["Department of Nuclear Medicine and Endocrinological Oncology, Gustave-Roussy Institute, Villejuif,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine and Endocrinological Oncology, Gustave-Roussy Institute, Villejuif,","institution_ids":["https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5067116958"],"corresponding_institution_ids":["https://openalex.org/I2801843802"],"apc_list":{"value":4250,"currency":"USD","value_usd":4250},"apc_paid":null,"fwci":0.9739,"has_fulltext":false,"cited_by_count":53,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.74799862,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"64","issue":"1","first_page":"110","last_page":"113"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11054","display_name":"Adrenal and Paraganglionic Tumors","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11054","display_name":"Adrenal and Paraganglionic Tumors","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.024399999529123306,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mitotane","display_name":"mitotane","score":0.9449999928474426},{"id":"https://openalex.org/keywords/adrenocortical-carcinoma","display_name":"adrenocortical carcinoma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cushing-s-syndrome","display_name":"Cushing's syndrome","score":0.9169999957084656},{"id":"https://openalex.org/keywords/treatment-thresholds","display_name":"treatment thresholds","score":0.6460000276565552},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6869999766349792},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8479999899864197},{"id":"https://openalex.org/keywords/endocrine-tumors","display_name":"endocrine tumors","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C2776735609","wikidata":"https://www.wikidata.org/wiki/Q417465","display_name":"Mitotane","level":3,"score":0.953545093536377},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8411251306533813},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.7564188838005066},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7517518997192383},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5647763013839722},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.5088820457458496},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48890987038612366},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44784489274024963},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4401790201663971},{"id":"https://openalex.org/C2781399356","wikidata":"https://www.wikidata.org/wiki/Q918285","display_name":"Adrenocortical carcinoma","level":2,"score":0.3654642105102539},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34181851148605347},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3364219665527344},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.138556569814682}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003480","descriptor_name":"Cushing Syndrome","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003480","descriptor_name":"Cushing Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003632","descriptor_name":"Dichlorodiphenyldichloroethane","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003632","descriptor_name":"Dichlorodiphenyldichloroethane","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003632","descriptor_name":"Dichlorodiphenyldichloroethane","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2265.2005.02403.x","doi":"https://doi.org/10.1111/j.1365-2265.2005.02403.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2265.2005.02403.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},{"id":"pmid:16402938","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16402938","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical endocrinology","raw_type":"Journal Article"},{"id":"pmh:oai:iris.uniroma1.it:11573/1325164","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11573/1325164","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1981265993","https://openalex.org/W1987174700","https://openalex.org/W2003238497","https://openalex.org/W2042262840","https://openalex.org/W2044828697","https://openalex.org/W2061962280","https://openalex.org/W2079874148","https://openalex.org/W2089304791","https://openalex.org/W4231739838","https://openalex.org/W4248664872"],"related_works":["https://openalex.org/W1967570987","https://openalex.org/W2319747565","https://openalex.org/W2527760793","https://openalex.org/W2128921375","https://openalex.org/W1995124360","https://openalex.org/W2090868589","https://openalex.org/W1987174700","https://openalex.org/W201095518","https://openalex.org/W1969723784","https://openalex.org/W4248664872"],"abstract_inverted_index":{"INTRODUCTION:":[0],"It":[1,73],"has":[2],"been":[3],"reported":[4],"that":[5,256],"the":[6,114,148,160,168,195,271,276],"therapeutic":[7,115,174,260,277],"threshold":[8,116,175,197],"of":[9,39,43,51,80,117,171,210,236],"mitotane,":[10,118],"plasma":[11,104,129,246,250,294],"level":[12,130,200,296],"above":[13],"14":[14],"microg/ml,":[15],"is":[16,262,304],"achieved":[17],"within":[18,90],"3-5":[19,280],"months":[20,281],"after":[21,232],"o,p'DDD":[22,45,105,126,184,237,259,295],"treatment":[23,46,185],"initiation":[24],"in":[25,48,60,178,212,223],"patients":[26,62,67,181,286],"with":[27,63,68,264],"adrenocortical":[28],"carcinoma":[29],"(ACC).":[30],"OBJECTIVE":[31],"AND":[32],"DESIGN:":[33],"We":[34],"evaluated":[35],"pharmacokinetic":[36],"and":[37,65,97,103,119,128,142,164,226,249,268,293],"tolerance":[38,96,102],"a":[40,77,145,257,288],"high-dose":[41,258],"schedule":[42,261,278],"pure":[44],"given":[47,138],"500-mg":[49],"tablets":[50],"mitotane":[52,199,247],"(Lysodren,":[53],"Bristol-Myers":[54],"Squibb,":[55],"HRA":[56],"Pharma,":[57],"Paris,":[58],"France)":[59],"four":[61,180,193],"ACC":[64],"two":[66,150],"Cushing's":[69],"syndrome-related":[70],"endocrine":[71],"tumours.":[72],"was":[74,84,121,131,176,204,221,243],"administered":[75],"at":[76,187,207],"starting":[78,136],"dosage":[79,137],"3":[81,219],"g/day,":[82],"which":[83],"rapidly":[85],"increased":[86],"to":[87,94,101,274,282],"6-9":[88],"g/day":[89],"2":[91,162,217,225],"weeks":[92,163,209],"according":[93,100],"digestive":[95],"then":[98],"adjusted":[99],"monitoring.":[106],"Patients":[107],"were":[108],"followed":[109],"up":[110],"until":[111],"they":[112],"reached":[113,177,206],"toxicity":[120,220,267],"recorded.":[122],"A":[123,239,301],"relationship":[124],"between":[125,140,245],"dose":[127,155,248],"sought.":[132],"RESULTS:":[133],"The":[134,152,173],"highest":[135],"ranged":[139,156],"6":[141,208],"9":[143],"g":[144,158,166],"day,":[146],"during":[147,159],"first":[149],"weeks.":[151,284],"daily":[153],"maintenance":[154],"4.5-9":[157],"next":[161],"3-9":[165],"by":[167],"second":[169,299],"month":[170],"treatment.":[172],"all":[179],"who":[182],"received":[183],"for":[186],"least":[188],"1":[189,227],"month.":[190],"Among":[191],"these":[192],"patients,":[194,228],"toxic":[196],"(plasma":[198],">":[201],"20":[202],"microg/ml)":[203],"even":[205],"therapy":[211],"three":[213],"patients.":[214],"Grade":[215],"1,":[216],"or":[218,234],"observed":[222],"3,":[224],"respectively.":[229],"Toxicity":[230],"resolved":[231],"reduction":[233],"discontinuation":[235],"therapy.":[238],"significant":[240],"linear":[241],"correlation":[242],"found":[244],"level.":[251],"CONCLUSIONS:":[252],"These":[253,285],"results":[254],"suggest":[255],"feasible":[263],"an":[265],"acceptable":[266],"may":[269],"shorten":[270],"time":[272],"required":[273],"reach":[275],"from":[279],"4":[283],"require":[287],"close":[289],"follow-up,":[290],"combining":[291],"clinical":[292],"monitoring":[297],"every":[298],"week.":[300],"confirmatory":[302],"study":[303],"ongoing.":[305]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2157310187","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
